Regulatory Review Focus Areas in Q1E-Based Submissions
Stability data submissions guided by ICH Q1E are critical components of drug product approval and lifecycle management. Global regulatory bodies such as the USFDA, EMA, CDSCO, and WHO routinely inspect these data to ensure statistical soundness and compliance. However, several recurring areas often attract scrutiny during regulatory review. This article details these key areas and…
Read More “Regulatory Review Focus Areas in Q1E-Based Submissions” »